Special Issue "Cellular, Molecular and Multi-Omics Approaches for the Investigation of Human Neurodevelopmental Disorders"
Deadline for manuscript submissions: 30 November 2023 | Viewed by 300
Interests: bioinformatics; high throughput sequencing technologies; neurological disorders; human molecular genetics; molecular biology; systems biology; computational biology; multi-omics data integration; stem cell models for mental disorders.
Interests: neurodegenerative and neurodevelopmental disorders; regenerative medicine; stem cells; brain organoids; neurons; astrocytes; neural progenitor cells; thyroid hormone; endocrine disruptors; complement system
Neurodevelopmental disorders (ND) involve a wide range of health conditions affecting the normal function of the brain and are characterized by early onset of clinical manifestations affecting mood, thinking and behavior, as well as impairments in cognition and motor function. Epidemiological studies indicate a high incidence of ND, affecting millions of people worldwide. To uncover the cellular and molecular mechanisms determining the pathological phenotypes found in ND, recent discoveries have demonstrated several cellular, molecular and genetic phenotypes that are exclusive to ND, with several of them used as biomarkers for their diagnosis as well as for novel drug targets for future therapeutic applications.
Dr. Roberto Hirochi Herai
Dr. Janaína Sena De Souza
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- neurodevelopmental disorders
- multi-omics technologies
- molecular pathways
- stem cell for disease modeling
- regenerative medicine